mRNA based vaccines as an alternative to conventional vaccine approaches

Zubda-tul-Hoor* and Muhammad Imran Qadir

In recent years, vaccines based on mRNA are providing protection against infectious diseases and treatment for cancer. These vaccines offer many advantages as compared to traditional vaccines. They can be rapidly and easily manufactured at a low cost and are reliable for administration. These vaccines can generate both cell-mediated and humoral immunity. Their administration is still limited because of the risk of quick degradation and ineffectiveness after delivery. Technological advancements are recently being made to overcome these issues. This review summarizes current mRNA vaccine development, safety concerns, advances in delivery systems, clinical trials, and various therapeutic applications of mRNA vaccines. 

Keywords:

Published on: Apr 29, 2022 Pages: 1-5

Full Text PDF Full Text HTML DOI: 10.17352/ojeb.000026
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat